BioSpace News Archive

The Global Biotechnology and Pharmaceutical Services Outsourcing Market to Reach US$ 70 Bn In 2022

Fact.MR – A Market research and competitive intelligence provider: The global biotechnology and pharmaceutical services outsourcing market is anticipated to hold a market valuation of US$ 70 Bn in 2022 and US$ 112.31 Bn by 2032.

March 1, 2022
·
6 min read
Amniocentesis Needle Market: The Hospitals Segment is Likely to Hold the Largest Market Share

Amniocentesis is a prenatal test also known as amniotic fluid test or AFT. It is carried out to diagnose the chromosomal abnormalities and fetal infections.

March 1, 2022
·
5 min read
Veterinary Gastrointestinal Endoscopes Market: The Esophagogastroduodenoscopy Segment is Likely to Expand at a Rapid pace During the Forecast Period

An endoscope is an instrument which is used to look deeply inside the body. Endoscopes may be flexible, rigid, capsule and robot assisted which can be used to examine the bladder, abdomen, and other internal organs.

March 1, 2022
·
5 min read
Drug Development

Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA2001

Saint Herblain, March1, 2022 – Valneva SE, a specialty vaccine company, announced that the National Health Regulatory Authority of the Kingdom of Bahrain has granted emergency use authorization for Valneva’s inactivated, adjuvanted COVID-19 vaccine, VLA2001.

March 1, 2022
·
5 min read
Biotech Bay

Lifebit and Boehringer Ingelheim announce partnership to capture transformational value of health data

The leading research-driven biopharmaceutical company Boehringer Ingelheim and precision medicine software company Lifebit Biotech, Ltd. announce partnership in which Lifebit will support Boehringer Ingelheim in building a scalable data, analytics, and infrastructure platform within its IT environment.

March 1, 2022
·
3 min read
Synapse Medicine raises $28M to scale its medication reconciliation platform

Synapse Medicine is one of the top growing health tech startups in Europe, with a strong track record on medication reconciliation.

March 1, 2022
·
4 min read
Business

Nordic Nanovector ASA: Results for the Fourth Quarter and Full Year 2021

Nordic Nanovector ASA announces its results for the fourth quarter and full year 2021.

March 1, 2022
·
8 min read
Drug Development

Nicox’s Partner Ocumension Obtains Positive Phase 3 Clinical Trial Results for ZERVIATE® in China

Nicox SA, an international ophthalmology company, announced positive results in a Chinese Phase 3 clinical trial of ZERVIATE®, 0.24%, run by its Chinese partner, Ocumension Therapeutics.

March 1, 2022
·
5 min read
Evotec Expands Molecular Patient Database with Unique Nephrotic Syndrome Cohort from the University of Bristol

Evotec SE announced that the Company has entered into a collaboration with the University of Bristol to expand the Company’s molecular patient database in the field of kidney diseases with a focus on nephrotic syndrome.

March 1, 2022
·
5 min read
Pharm Country

Fujirebio enters the field of fully automated blood-based Alzheimer’s disease biomarker testing with the release of the Lumipulse® G pTau 181 Plasma assay for Research Use Only

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio announced the availability of the Lumipulse G pTau 181 Plasma assay for the fully automated LUMIPULSE G immunoassay systems.

March 1, 2022
·
4 min read